Sarah Benezech

Mrs. Sarah Benezech

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2019 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
FMFlora Magnotti
Flora Magnotti
LLLucie Lefeuvre
Lucie Lefeuvre
SBSarah Benezech
Sarah Benezech
TMTiphaine Malsot
Tiphaine Malsot
LWLouis Waeckel
Louis Waeckel
THThomas Henry
Thomas Henry
Familial Mediterranean fever (FMF) is the most frequent hereditary systemic autoinflammatory syndrome. FMF is usually caused by biallelic mutations in the MEFV gene, encoding Pyrin. Conclusive genetic evidence lacks for about 30% of patients diagnosed with clinical FMF. Pyrin is an inflammasome sensor maintained inactive by two kinases (PKN1/2). The consequences of MEFV mutations on inflammasome activation are still poorly understood. Here, we demonstrate that PKC superfamily inhibitors trigger inflammasome activation in monocytes from FMF patients while they trigger a delayed apoptosis in monocytes from healthy donors. The expression of the pathogenic p.M694V MEFV allele is necessary and sufficient for PKC inhibitors (or mutations precluding Pyrin phosphorylation) to trigger caspase‐1‐ and gasdermin D‐mediated pyroptosis. In line with colchicine efficacy in patients, colchicine fully blocks this response in FMF patients’ monocytes. These results indicate that Pyrin inflammasome activation is solely controlled by Pyrin (de)phosphorylation in FMF patients while a second control mechanism restricts its activation in healthy donors/non‐FMF patients. This study paves the way toward a functional characterization of MEFV variants and a functional test to diagnose FMF.

30 August 2024 in Science Advances
Verified
Journal Article
Open access
KPKévin Pouxvielh
Kévin Pouxvielh
MMMarie Marotel
Marie Marotel
ADAnnabelle Drouillard
Annabelle Drouillard
MVMarine Villard
Marine Villard
MMMarion Moreews
Marion Moreews
TWThierry Walzer
Thierry Walzer
Natural killer (NK) cells often become dysfunctional during tumor progression, but the molecular mechanisms underlying this phenotype remain unclear. To explore this phenomenon, we set up mouse lymphoma models activating or not activating NK cells. Both tumor types elicited type I interferon production, leading to the expression of a T cell exhaustion-like signature in NK cells, which included immune checkpoint proteins (ICPs). However, NK cell dysfunction occurred exclusively in the tumor model that triggered NK cell activation. Moreover, ICP-positive NK cells demonstrated heightened reactivity compared to negative ones. Furthermore, the onset of NK cell dysfunction was swift and temporally dissociated from ICPs induction, which occurred as a later event during tumor growth. Last, NK cell responsiveness was restored when stimulation was discontinued, and interleukin-15 had a positive impact on this reversion. Therefore, our data demonstrate that the reactivity of NK cells is dynamically controlled and that NK cell dysfunction is a reversible process uncoupled from the expression of ICPs.

3 January 2025 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
NCNicolas Kern Coquillat
Nicolas Kern Coquillat
LPLouis Picq
Louis Picq
AHAmeline Hamond
Ameline Hamond
PMPierre Megy
Pierre Megy
SBSarah Benezech
Sarah Benezech
AMAntoine Marçais
Antoine Marçais

1 December 2020 in European Journal of Cancer
Verified
Journal Article
Closed access
ARAlba Rubio-San-Simón
Alba Rubio-San-Simón
NANicolas André
Nicolas André
MCMaria Giuseppina Cefalo
Maria Giuseppina Cefalo
IAIsabelle Aerts
Isabelle Aerts
ACAlicia Castañeda
Alicia Castañeda
FSFrancisco Jose Bautista Sirvent
Francisco Jose Bautista Sirvent

30 November 2023 in New England Journal of Medicine
Verified
Journal Article
Closed access
SBSarah Benezech
Sarah Benezech
LKLiliane Khoryati
Liliane Khoryati
JCJade Cognard
Jade Cognard
SNStejara A. Netea
Stejara A. Netea
TKTaushif Khan
Taushif Khan
ABAlexandre Belot
Alexandre Belot

1 April 2022 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YRYamila Rocca
Yamila Rocca
KPKevin Pouxvielh
Kevin Pouxvielh
MMMarie Marotel
Marie Marotel
SBSarah Benezech
Sarah Benezech
BJBaptiste Jaeger
Baptiste Jaeger
TWThierry Walzer
Thierry Walzer
NK cell receptors allow NK cells to recognize targets such as tumor cells. Many of them are expressed on a subset of NK cells, independently of each other, which creates a vast diversity of receptor combinations. Whether these combinations influence NK cell antitumor responses is not well understood. We addressed this question in the C57BL/6 mouse model and analyzed the individual effector response of 444 mouse NK cell subsets, defined by combinations of 12 receptors, against tumor cell lines originating from different tissues and mouse strains. We found a wide range of reactivity among NK subsets, but the same hierarchy of responses was observed for the different tumor types, showing that the repertoire of NK cell receptors does not encode for different tumor specificities but for different intrinsic reactivities. The coexpression of CD27, NKG2A, and DNAM-1 identified subsets with relative cytotoxic specialization, whereas reciprocally, CD11b and KLRG1 defined the best IFN-γ producers. The expression of educating receptors Ly49C, Ly49I, and NKG2A was also strongly correlated with IFN-γ production, but this effect was suppressed by unengaged receptors Ly49A, Ly49F, and Ly49G2. Finally, IL-15 coordinated NK cell effector functions, but education and unbound inhibitory receptors retained some influence on their response. Collectively, these data refine our understanding of the mechanisms governing NK cell reactivity, which could help design new NK cell therapy protocols.